Suppr超能文献

抗病毒治疗贝尔麻痹的疗效比较:系统评价和网络荟萃分析。

Effectiveness comparisons of antiviral treatments for Bell palsy: a systematic review and network meta-analysis.

机构信息

Department of Stomatology, Shengjing Hospital of China Medical University, Shenyang, 110004, LN, China.

出版信息

J Neurol. 2022 Mar;269(3):1353-1367. doi: 10.1007/s00415-021-10487-9. Epub 2021 Mar 5.

Abstract

OBJECTIVES

Antiviral treatments for Bell palsy have been widely used, but there is no definite conclusion of which is the most effective antiviral drug. We conducted a systematic review of randomized controlled trials (RCTs) including network meta-analysis to investigate the comparative effectiveness of antiviral treatments for Bell palsy.

DATA

RCTs comparing effectiveness between antiviral treatments and placebo were included. Risk of bias within and across studies was assessed with the Cochrane tool and the GRADE approach, respectively. Random-effects pairwise meta-analyses were conducted, followed by network meta-analysis.

SOURCES

Three electronic databases were searched from inception to May 18, 2020.

STUDY SELECTION

11 trials and 3393 patients with four arms and eleven contrasts were included.

RESULTS

Significant differences were observed between placebo and famciclovir with respect to overall recovery and no statistically significant differences were found from other comparisons. Treatment ranking based on the evidence network indicated that famciclovir shared the best results, followed by valacyclovir, acyclovir, and finally placebo. Adverse events of famciclovir were too rare and slight to be analyzed. Our confidence in pairwise comparisons was moderate to low, due to study limitations, inconsistency, and imprecision; our confidence in ranking was moderate, due to study limitations. Inconsistency is not deemed to exist by a loop-specific approach and node-splitting procedure. Results of exploring publication bias are satisfying.

CONCLUSIONS

According to pairwise and network comparisons, famciclovir could be better than placebo and the effectiveness of other antiviral treatments are similar. For clinical efficacy, famciclovir obtains the best recovery rate of facial function for Bell palsy. Acyclovir has the lowest rate of synkinesis, though, it is not adequately recommended and more superior trails are needed in the future.

摘要

目的

抗病毒治疗贝尔麻痹已被广泛应用,但哪种抗病毒药物最有效尚无定论。我们进行了一项系统综述,纳入了网络荟萃分析,以评估抗病毒治疗贝尔麻痹的疗效。

数据

纳入比较抗病毒治疗与安慰剂疗效的随机对照试验(RCT)。采用 Cochrane 工具和 GRADE 方法评估各研究内及各研究间的偏倚风险。进行了随机效应成对荟萃分析,然后进行网络荟萃分析。

来源

从研究开始至 2020 年 5 月 18 日,检索了 3 个电子数据库。

研究选择

纳入 11 项试验,共 3393 例患者,涉及 4 个治疗组和 11 个对比。

结果

在总体恢复方面,安慰剂与泛昔洛韦之间存在显著差异,而其他比较则无统计学差异。基于证据网络的治疗排序表明,泛昔洛韦疗效最好,其后依次为伐昔洛韦、阿昔洛韦和安慰剂。泛昔洛韦的不良反应罕见且轻微,无法进行分析。由于研究局限性、不一致性和不精确性,我们对成对比较的信心为中等到低;由于研究局限性,我们对排序的信心为中等到高。采用环路特异性方法和节点分割程序,并未发现存在不一致性。对发表偏倚的探索结果令人满意。

结论

根据成对比较和网络比较,泛昔洛韦可能优于安慰剂,其他抗病毒治疗的疗效相似。在临床疗效方面,泛昔洛韦对面神经麻痹的面部功能恢复率最高。虽然阿昔洛韦的联带运动发生率最低,但不推荐充分使用,未来需要进行更优的试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验